Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer

doi:10.3748/wjg.v11.i18.2744

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3252)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

348

HTML

2495

Figures (1-2)

227

Tables (1-2)

182

Sum=3252

May 14, 2005 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. May 14, 2005; 11(18): 2744-2747
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2744

Open in New Tab Full Size Figure Download Figure

Figure 1 Immunohistochemical staining of pBcl-2 and pBax in pancreatic cancer (original magnification, ×200). A: pBcl-2 immunostaining was stained in cytoplasm of tumor cells; B: pBax immunostaining was stained in cytoplasm of tumor cells.

Open in New Tab Full Size Figure Download Figure

Figure 2 Survival curves with Kaplan-Meier method was applied in analyzing the influence of pBcl-2, pBax and their combined expression on post-surgical survival time.

Citation: Dong M, Zhou JP, Zhang H, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(18): 2744-2747
URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2744.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2744